The most prominent diagnostic difficulty associated with PSA screening is the detection of PCa in patients with PSA levels of 4–20 ng/ml, which is mainly reflected by relatively high false-positive and false-negative rates. This evidence concerns the gene KLK3 and posterior cortical atrophy.